

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to insecticide (GO:0017085) | 9.56903974 |
| 2 | * catecholamine transport (GO:0051937) | 7.78711662 |
| 3 | mating behavior (GO:0007617) | 7.58169147 |
| 4 | synaptic transmission, dopaminergic (GO:0001963) | 7.57385838 |
| 5 | toxin metabolic process (GO:0009404) | 7.29010464 |
| 6 | * catecholamine biosynthetic process (GO:0042423) | 7.04262599 |
| 7 | * catechol-containing compound biosynthetic process (GO:0009713) | 7.04262599 |
| 8 | neuron cell-cell adhesion (GO:0007158) | 6.47331632 |
| 9 | negative regulation of neurotransmitter transport (GO:0051589) | 6.28152715 |
| 10 | regulation of dopamine secretion (GO:0014059) | 6.10626808 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 5.97030133 |
| 12 | glutamate secretion (GO:0014047) | 5.89286912 |
| 13 | multicellular organismal aging (GO:0010259) | 5.86254177 |
| 14 | ethanol oxidation (GO:0006069) | 5.78137530 |
| 15 | * dopamine metabolic process (GO:0042417) | 5.51228822 |
| 16 | behavioral response to cocaine (GO:0048148) | 5.35279645 |
| 17 | neurotransmitter catabolic process (GO:0042135) | 5.13212931 |
| 18 | embryonic camera-type eye morphogenesis (GO:0048596) | 5.01754372 |
| 19 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 4.98937825 |
| 20 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 4.98937825 |
| 21 | cellular response to nicotine (GO:0071316) | 4.96463742 |
| 22 | attachment of spindle microtubules to kinetochore (GO:0008608) | 4.92249985 |
| 23 | glycoside metabolic process (GO:0016137) | 4.84278442 |
| 24 | tyrosine metabolic process (GO:0006570) | 4.79792570 |
| 25 | aromatic amino acid family metabolic process (GO:0009072) | 4.77237658 |
| 26 | synaptic transmission, cholinergic (GO:0007271) | 4.76110896 |
| 27 | response to amphetamine (GO:0001975) | 4.66604915 |
| 28 | * neurotransmitter biosynthetic process (GO:0042136) | 4.62904986 |
| 29 | * monoamine transport (GO:0015844) | 4.59760575 |
| 30 | inositol phosphate dephosphorylation (GO:0046855) | 4.57920635 |
| 31 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 4.57920635 |
| 32 | positive regulation of cell size (GO:0045793) | 4.56390086 |
| 33 | positive regulation of glomerulus development (GO:0090193) | 4.54612821 |
| 34 | establishment of synaptic vesicle localization (GO:0097480) | 4.53272456 |
| 35 | synaptic vesicle transport (GO:0048489) | 4.53272456 |
| 36 | cellular response to ammonium ion (GO:0071242) | 4.40997443 |
| 37 | * phenol-containing compound biosynthetic process (GO:0046189) | 4.32334060 |
| 38 | regulation of clathrin-mediated endocytosis (GO:2000369) | 4.32080057 |
| 39 | * response to cocaine (GO:0042220) | 4.30123589 |
| 40 | positive regulation of vesicle fusion (GO:0031340) | 4.19997185 |
| 41 | negative regulation of microtubule polymerization (GO:0031115) | 4.19891199 |
| 42 | * regulation of dopamine metabolic process (GO:0042053) | 4.18664643 |
| 43 | * regulation of catecholamine metabolic process (GO:0042069) | 4.18664643 |
| 44 | response to corticosterone (GO:0051412) | 4.17844021 |
| 45 | benzene-containing compound metabolic process (GO:0042537) | 4.11884159 |
| 46 | response to water (GO:0009415) | 4.10763280 |
| 47 | inositol phosphate catabolic process (GO:0071545) | 4.09078821 |
| 48 | neurotransmitter secretion (GO:0007269) | 4.00382352 |
| 49 | serotonin metabolic process (GO:0042428) | 4.00361443 |
| 50 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.94988660 |
| 51 | cerebellar Purkinje cell layer development (GO:0021680) | 3.93544082 |
| 52 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.89745909 |
| 53 | ethanol metabolic process (GO:0006067) | 3.88501031 |
| 54 | * response to nicotine (GO:0035094) | 3.87637672 |
| 55 | * regulation of neurotransmitter levels (GO:0001505) | 3.87224731 |
| 56 | regulation of oxidative phosphorylation (GO:0002082) | 3.84577555 |
| 57 | circadian behavior (GO:0048512) | 3.82598027 |
| 58 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.79054097 |
| 59 | response to amine (GO:0014075) | 3.74008194 |
| 60 | vocalization behavior (GO:0071625) | 3.73949837 |
| 61 | opioid receptor signaling pathway (GO:0038003) | 3.73221273 |
| 62 | behavioral response to nicotine (GO:0035095) | 3.71324002 |
| 63 | primary amino compound metabolic process (GO:1901160) | 3.70421594 |
| 64 | cellular response to drug (GO:0035690) | 3.70341305 |
| 65 | eating behavior (GO:0042755) | 3.69359371 |
| 66 | * catechol-containing compound metabolic process (GO:0009712) | 3.69084385 |
| 67 | * catecholamine metabolic process (GO:0006584) | 3.69084385 |
| 68 | response to zinc ion (GO:0010043) | 3.62953456 |
| 69 | rhythmic behavior (GO:0007622) | 3.62009935 |
| 70 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.60402655 |
| 71 | neuron maturation (GO:0042551) | 3.58270495 |
| 72 | * neurotransmitter metabolic process (GO:0042133) | 3.58237320 |
| 73 | neurofilament cytoskeleton organization (GO:0060052) | 3.58195355 |
| 74 | multi-organism reproductive behavior (GO:0044705) | 3.53965226 |
| 75 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.53106773 |
| 76 | eye photoreceptor cell development (GO:0042462) | 3.51499958 |
| 77 | striatum development (GO:0021756) | 3.50185957 |
| 78 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 3.47328250 |
| 79 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 3.44304968 |
| 80 | * neurotransmitter transport (GO:0006836) | 3.43825946 |
| 81 | enteric nervous system development (GO:0048484) | 3.43298284 |
| 82 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.41309830 |
| 83 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.41309830 |
| 84 | response to manganese ion (GO:0010042) | 3.40321947 |
| 85 | response to mineralocorticoid (GO:0051385) | 3.39849687 |
| 86 | L-phenylalanine catabolic process (GO:0006559) | 3.39836675 |
| 87 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.39836675 |
| 88 | protein depolymerization (GO:0051261) | 3.38544770 |
| 89 | regulation of neurotransmitter uptake (GO:0051580) | 3.37207190 |
| 90 | positive regulation of cellular response to oxidative stress (GO:1900409) | 3.37123890 |
| 91 | positive regulation of response to oxidative stress (GO:1902884) | 3.37123890 |
| 92 | positive regulation of neurotransmitter transport (GO:0051590) | 3.35432757 |
| 93 | regulation of vesicle fusion (GO:0031338) | 3.34695100 |
| 94 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.34301121 |
| 95 | establishment of vesicle localization (GO:0051650) | 3.33632849 |
| 96 | insulin secretion (GO:0030073) | 3.31421350 |
| 97 | embryonic eye morphogenesis (GO:0048048) | 3.30720806 |
| 98 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.30467753 |
| 99 | ATP synthesis coupled proton transport (GO:0015986) | 3.30467753 |
| 100 | reproductive behavior (GO:0019098) | 3.29769362 |
| 101 | response to salt stress (GO:0009651) | 3.28939099 |
| 102 | synaptic vesicle endocytosis (GO:0048488) | 3.28887195 |
| 103 | photoreceptor cell development (GO:0042461) | 3.28792112 |
| 104 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.25793318 |
| 105 | innervation (GO:0060384) | 3.25108932 |
| 106 | auditory behavior (GO:0031223) | 3.24247347 |
| 107 | norepinephrine metabolic process (GO:0042415) | 3.24192100 |
| 108 | synaptic vesicle maturation (GO:0016188) | 3.23621157 |
| 109 | regulation of synaptic vesicle transport (GO:1902803) | 3.20647341 |
| 110 | intraspecies interaction between organisms (GO:0051703) | 3.18603100 |
| 111 | social behavior (GO:0035176) | 3.18603100 |
| 112 | lactate metabolic process (GO:0006089) | 3.17251339 |
| 113 | response to xenobiotic stimulus (GO:0009410) | 3.16258737 |
| 114 | pigmentation (GO:0043473) | 3.15333208 |
| 115 | respiratory electron transport chain (GO:0022904) | 3.13677609 |
| 116 | neuron-neuron synaptic transmission (GO:0007270) | 3.13264308 |
| 117 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.12873324 |
| 118 | regulation of catecholamine secretion (GO:0050433) | 3.11307726 |
| 119 | response to electrical stimulus (GO:0051602) | 3.10896913 |
| 120 | regulation of glomerulus development (GO:0090192) | 3.09967489 |
| 121 | regulation of synapse structural plasticity (GO:0051823) | 3.09504039 |
| 122 | endocytic recycling (GO:0032456) | 3.07720093 |
| 123 | positive regulation of growth hormone secretion (GO:0060124) | 3.07343901 |
| 124 | neuronal action potential (GO:0019228) | 3.07180771 |
| 125 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 3.07174386 |
| 126 | electron transport chain (GO:0022900) | 3.06789113 |
| 127 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.06536269 |
| 128 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.04739715 |
| 129 | Notch signaling involved in heart development (GO:0061314) | 3.04734033 |
| 130 | response to histamine (GO:0034776) | 3.01315340 |
| 131 | transferrin transport (GO:0033572) | 3.00182186 |
| 132 | cellular response to epinephrine stimulus (GO:0071872) | 2.99353460 |
| 133 | acid secretion (GO:0046717) | 2.98538420 |
| 134 | grooming behavior (GO:0007625) | 2.97726627 |
| 135 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.97256055 |
| 136 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.97119803 |
| 137 | organic cation transport (GO:0015695) | 2.93425352 |
| 138 | sulfation (GO:0051923) | 2.92309015 |
| 139 | negative regulation of membrane potential (GO:0045837) | 2.87562850 |
| 140 | regulation of neurotransmitter transport (GO:0051588) | 2.87249719 |
| 141 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.81970966 |
| 142 | alkaloid metabolic process (GO:0009820) | 14.2716007 |
| 143 | * dopamine biosynthetic process (GO:0042416) | 12.2290028 |
| 144 | * dopamine transport (GO:0015872) | 11.2740042 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.67481337 |
| 2 | TAF15_26573619_Chip-Seq_HEK293_Human | 4.77522396 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.15305169 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.41946606 |
| 5 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.35141786 |
| 6 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 3.33553547 |
| 7 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 3.14175030 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.05889256 |
| 9 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.99564513 |
| 10 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.87603284 |
| 11 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.82439140 |
| 12 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.56875853 |
| 13 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.55255050 |
| 14 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.30692608 |
| 15 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.30427087 |
| 16 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.28457415 |
| 17 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.27670519 |
| 18 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.26040583 |
| 19 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.25671154 |
| 20 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.19217342 |
| 21 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.17241095 |
| 22 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.16609459 |
| 23 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 2.16192380 |
| 24 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.13622402 |
| 25 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.12183959 |
| 26 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.05693917 |
| 27 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.05693917 |
| 28 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.00453606 |
| 29 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.97405312 |
| 30 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.95469449 |
| 31 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.95223355 |
| 32 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.94913514 |
| 33 | TP53_16413492_ChIP-PET_HCT116_Human | 1.87667456 |
| 34 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.85160146 |
| 35 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.83709897 |
| 36 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.77471599 |
| 37 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.76964269 |
| 38 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.76002047 |
| 39 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.75947556 |
| 40 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.73301313 |
| 41 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.73190295 |
| 42 | P300_19829295_ChIP-Seq_ESCs_Human | 1.72489736 |
| 43 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.57359235 |
| 44 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.57317180 |
| 45 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.56937251 |
| 46 | VDR_22108803_ChIP-Seq_LS180_Human | 1.56642511 |
| 47 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.56052082 |
| 48 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.54235184 |
| 49 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.52663905 |
| 50 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.44556983 |
| 51 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.42272325 |
| 52 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.40283545 |
| 53 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.40206105 |
| 54 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.39572431 |
| 55 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.38672280 |
| 56 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.38240023 |
| 57 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.36872749 |
| 58 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.36417137 |
| 59 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.36391359 |
| 60 | FUS_26573619_Chip-Seq_HEK293_Human | 1.34265495 |
| 61 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29541912 |
| 62 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28162714 |
| 63 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.27964452 |
| 64 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.26405156 |
| 65 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.25177056 |
| 66 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.23712542 |
| 67 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.21744011 |
| 68 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20649839 |
| 69 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.19986446 |
| 70 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.19625789 |
| 71 | AR_25329375_ChIP-Seq_VCAP_Human | 1.19334925 |
| 72 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12436370 |
| 73 | * CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.12327936 |
| 74 | STAT3_23295773_ChIP-Seq_U87_Human | 1.11357688 |
| 75 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.10405702 |
| 76 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.09701218 |
| 77 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.09516940 |
| 78 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.08844592 |
| 79 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.08440987 |
| 80 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.07376409 |
| 81 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.06718215 |
| 82 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.06318408 |
| 83 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.06173883 |
| 84 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.05345588 |
| 85 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.05345588 |
| 86 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.04997023 |
| 87 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.04962475 |
| 88 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.03683796 |
| 89 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.03300580 |
| 90 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.03173539 |
| 91 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.01558482 |
| 92 | TCF4_23295773_ChIP-Seq_U87_Human | 1.01437642 |
| 93 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.00545884 |
| 94 | JUN_21703547_ChIP-Seq_K562_Human | 1.00085997 |
| 95 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.99291625 |
| 96 | EWS_26573619_Chip-Seq_HEK293_Human | 0.99013792 |
| 97 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.98969424 |
| 98 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.97777026 |
| 99 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97208651 |
| 100 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.96621695 |
| 101 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.96360991 |
| 102 | MNX1_26342078_ChIP-Seq_MIN6-4N_Mouse | 0.94679765 |
| 103 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93067240 |
| 104 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92129768 |
| 105 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.92129768 |
| 106 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 0.90178003 |
| 107 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.89641434 |
| 108 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.89574633 |
| 109 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.89552516 |
| 110 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.87708634 |
| 111 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.86881717 |
| 112 | AR_19668381_ChIP-Seq_PC3_Human | 0.86612833 |
| 113 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.86144417 |
| 114 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.86140520 |
| 115 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.84885725 |
| 116 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.84177287 |
| 117 | KDM2B_26808549_Chip-Seq_REH_Human | 0.83463044 |
| 118 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.83042049 |
| 119 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.82853765 |
| 120 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.82807833 |
| 121 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.81475738 |
| 122 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.80607959 |
| 123 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.80350026 |
| 124 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.80147924 |
| 125 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.80036633 |
| 126 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.80036633 |
| 127 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.79913931 |
| 128 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79463140 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.09924237 |
| 2 | MP0003880_abnormal_central_pattern | 6.38442872 |
| 3 | * MP0001905_abnormal_dopamine_level | 5.52046867 |
| 4 | MP0001529_abnormal_vocalization | 4.68502526 |
| 5 | MP0006276_abnormal_autonomic_nervous | 3.84348464 |
| 6 | MP0004859_abnormal_synaptic_plasticity | 3.57272108 |
| 7 | MP0002822_catalepsy | 3.50179192 |
| 8 | MP0005248_abnormal_Harderian_gland | 2.97428899 |
| 9 | * MP0003635_abnormal_synaptic_transmissio | 2.86074574 |
| 10 | MP0002909_abnormal_adrenal_gland | 2.53675892 |
| 11 | MP0002064_seizures | 2.46047518 |
| 12 | MP0005409_darkened_coat_color | 2.46023991 |
| 13 | MP0009745_abnormal_behavioral_response | 2.43779223 |
| 14 | MP0001501_abnormal_sleep_pattern | 2.37651217 |
| 15 | MP0003122_maternal_imprinting | 2.34417993 |
| 16 | MP0005423_abnormal_somatic_nervous | 2.28646210 |
| 17 | MP0001188_hyperpigmentation | 2.12877356 |
| 18 | MP0002876_abnormal_thyroid_physiology | 2.05502071 |
| 19 | MP0000569_abnormal_digit_pigmentation | 2.00920088 |
| 20 | MP0001486_abnormal_startle_reflex | 1.98676695 |
| 21 | MP0001968_abnormal_touch/_nociception | 1.97722932 |
| 22 | MP0002736_abnormal_nociception_after | 1.93497602 |
| 23 | MP0001664_abnormal_digestion | 1.92185454 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 1.91898447 |
| 25 | * MP0002572_abnormal_emotion/affect_behav | 1.89192654 |
| 26 | MP0002733_abnormal_thermal_nociception | 1.88297989 |
| 27 | * MP0002063_abnormal_learning/memory/cond | 1.84668988 |
| 28 | MP0002638_abnormal_pupillary_reflex | 1.83661876 |
| 29 | MP0005535_abnormal_body_temperature | 1.82911029 |
| 30 | * MP0004924_abnormal_behavior | 1.81668516 |
| 31 | * MP0005386_behavior/neurological_phenoty | 1.81668516 |
| 32 | MP0002837_dystrophic_cardiac_calcinosis | 1.78146129 |
| 33 | MP0001440_abnormal_grooming_behavior | 1.72958327 |
| 34 | MP0002067_abnormal_sensory_capabilities | 1.64638042 |
| 35 | * MP0009046_muscle_twitch | 1.62805198 |
| 36 | MP0003868_abnormal_feces_composition | 1.58149710 |
| 37 | MP0002877_abnormal_melanocyte_morpholog | 1.45064086 |
| 38 | MP0001970_abnormal_pain_threshold | 1.44310645 |
| 39 | MP0000639_abnormal_adrenal_gland | 1.41792973 |
| 40 | MP0002332_abnormal_exercise_endurance | 1.41400920 |
| 41 | MP0002090_abnormal_vision | 1.36615909 |
| 42 | MP0002184_abnormal_innervation | 1.35946355 |
| 43 | MP0000538_abnormal_urinary_bladder | 1.34604148 |
| 44 | MP0002734_abnormal_mechanical_nocicepti | 1.33391769 |
| 45 | * MP0002272_abnormal_nervous_system | 1.30267103 |
| 46 | MP0003632_abnormal_nervous_system | 1.29654645 |
| 47 | * MP0002557_abnormal_social/conspecific_i | 1.29343560 |
| 48 | MP0004043_abnormal_pH_regulation | 1.23855177 |
| 49 | MP0004270_analgesia | 1.22654644 |
| 50 | MP0005646_abnormal_pituitary_gland | 1.17094817 |
| 51 | MP0004811_abnormal_neuron_physiology | 1.12439915 |
| 52 | MP0002089_abnormal_postnatal_growth/wei | 1.11790604 |
| 53 | * MP0002066_abnormal_motor_capabilities/c | 1.10537526 |
| 54 | MP0004142_abnormal_muscle_tone | 1.09627213 |
| 55 | MP0005388_respiratory_system_phenotype | 1.08157955 |
| 56 | MP0002133_abnormal_respiratory_system | 1.08157955 |
| 57 | MP0006072_abnormal_retinal_apoptosis | 1.03991406 |
| 58 | MP0003315_abnormal_perineum_morphology | 1.02749679 |
| 59 | MP0000955_abnormal_spinal_cord | 1.02120539 |
| 60 | MP0002735_abnormal_chemical_nociception | 1.00495557 |
| 61 | MP0000230_abnormal_systemic_arterial | 1.00014673 |
| 62 | MP0000778_abnormal_nervous_system | 0.99202312 |
| 63 | MP0003866_abnormal_defecation | 0.98547069 |
| 64 | MP0003879_abnormal_hair_cell | 0.97709439 |
| 65 | MP0008874_decreased_physiological_sensi | 0.97151829 |
| 66 | * MP0008872_abnormal_physiological_respon | 0.96076025 |
| 67 | MP0005187_abnormal_penis_morphology | 0.95794802 |
| 68 | MP0003329_amyloid_beta_deposits | 0.95626588 |
| 69 | MP0000751_myopathy | 0.95034117 |
| 70 | MP0003631_nervous_system_phenotype | 0.94274423 |
| 71 | MP0001944_abnormal_pancreas_morphology | 0.92072596 |
| 72 | MP0000013_abnormal_adipose_tissue | 0.90086547 |
| 73 | MP0004883_abnormal_blood_vessel | 0.89902226 |
| 74 | MP0005171_absent_coat_pigmentation | 0.87699521 |
| 75 | MP0002751_abnormal_autonomic_nervous | 0.87114806 |
| 76 | MP0000747_muscle_weakness | 0.85821187 |
| 77 | MP0009703_decreased_birth_body | 0.85007666 |
| 78 | MP0001502_abnormal_circadian_rhythm | 0.83316205 |
| 79 | MP0004742_abnormal_vestibular_system | 0.83225840 |
| 80 | MP0003718_maternal_effect | 0.81637787 |
| 81 | MP0003786_premature_aging | 0.79954395 |
| 82 | MP0001984_abnormal_olfaction | 0.79485372 |
| 83 | MP0005379_endocrine/exocrine_gland_phen | 0.79099901 |
| 84 | MP0006035_abnormal_mitochondrial_morpho | 0.78000171 |
| 85 | * MP0002882_abnormal_neuron_morphology | 0.77314327 |
| 86 | MP0000534_abnormal_ureter_morphology | 0.74763831 |
| 87 | MP0008875_abnormal_xenobiotic_pharmacok | 0.74670411 |
| 88 | MP0001177_atelectasis | 0.74213835 |
| 89 | MP0003890_abnormal_embryonic-extraembry | 0.73700649 |
| 90 | MP0001756_abnormal_urination | 0.73595397 |
| 91 | MP0004084_abnormal_cardiac_muscle | 0.72856180 |
| 92 | MP0003787_abnormal_imprinting | 0.71697473 |
| 93 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.71613415 |
| 94 | MP0001485_abnormal_pinna_reflex | 0.70233046 |
| 95 | MP0010386_abnormal_urinary_bladder | 0.69759990 |
| 96 | MP0002069_abnormal_eating/drinking_beha | 0.69218252 |
| 97 | MP0003195_calcinosis | 0.67618319 |
| 98 | MP0003942_abnormal_urinary_system | 0.66631859 |
| 99 | MP0001299_abnormal_eye_distance/ | 0.66626271 |
| 100 | MP0002163_abnormal_gland_morphology | 0.65872844 |
| 101 | MP0004885_abnormal_endolymph | 0.65617358 |
| 102 | MP0002229_neurodegeneration | 0.65071156 |
| 103 | MP0005410_abnormal_fertilization | 0.64792428 |
| 104 | MP0005394_taste/olfaction_phenotype | 0.63533282 |
| 105 | MP0005499_abnormal_olfactory_system | 0.63533282 |
| 106 | MP0008569_lethality_at_weaning | 0.63235155 |
| 107 | MP0001340_abnormal_eyelid_morphology | 0.62974777 |
| 108 | MP0002254_reproductive_system_inflammat | 0.62374031 |
| 109 | MP0002009_preneoplasia | 0.62372236 |
| 110 | MP0000462_abnormal_digestive_system | 0.61903359 |
| 111 | MP0005058_abnormal_lysosome_morphology | 0.60913511 |
| 112 | MP0010234_abnormal_vibrissa_follicle | 0.60673168 |
| 113 | MP0001943_abnormal_respiration | 0.60492976 |
| 114 | MP0005164_abnormal_response_to | 0.60472619 |
| 115 | MP0004858_abnormal_nervous_system | 0.60472400 |
| 116 | MP0005266_abnormal_metabolism | 0.60127906 |
| 117 | MP0005376_homeostasis/metabolism_phenot | 0.59225774 |
| 118 | MP0001765_abnormal_ion_homeostasis | 0.58711706 |
| 119 | MP0010770_preweaning_lethality | 0.58151867 |
| 120 | MP0002082_postnatal_lethality | 0.58151867 |
| 121 | * MP0002152_abnormal_brain_morphology | 0.57763957 |
| 122 | MP0001963_abnormal_hearing_physiology | 0.57377412 |
| 123 | MP0003183_abnormal_peptide_metabolism | 0.57262683 |
| 124 | MP0010768_mortality/aging | 0.56892621 |
| 125 | MP0003633_abnormal_nervous_system | 0.56595127 |
| 126 | MP0005623_abnormal_meninges_morphology | 0.56145482 |
| 127 | MP0005310_abnormal_salivary_gland | 0.55296612 |
| 128 | MP0006036_abnormal_mitochondrial_physio | 0.53964927 |
| 129 | MP0008873_increased_physiological_sensi | 0.53554249 |
| 130 | MP0000681_abnormal_thyroid_gland | 0.52719073 |
| 131 | MP0005551_abnormal_eye_electrophysiolog | 0.50088254 |
| 132 | MP0004145_abnormal_muscle_electrophysio | 0.48970345 |
| 133 | MP0002233_abnormal_nose_morphology | 0.46516176 |
| 134 | MP0004085_abnormal_heartbeat | 0.46414778 |
| 135 | MP0001346_abnormal_lacrimal_gland | 0.45375121 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pheochromocytoma (HP:0002666) | 7.65239538 |
| 2 | Postural instability (HP:0002172) | 7.14671797 |
| 3 | Neuroendocrine neoplasm (HP:0100634) | 6.96915603 |
| 4 | Abnormal pupillary function (HP:0007686) | 6.66207256 |
| 5 | Hypothermia (HP:0002045) | 6.60921174 |
| 6 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 6.56639640 |
| 7 | Visual hallucinations (HP:0002367) | 6.18434490 |
| 8 | Potter facies (HP:0002009) | 5.91304461 |
| 9 | Facial shape deformation (HP:0011334) | 5.91304461 |
| 10 | Failure to thrive in infancy (HP:0001531) | 5.65800788 |
| 11 | Cerebral hemorrhage (HP:0001342) | 5.19662400 |
| 12 | Hypokinesia (HP:0002375) | 4.91954156 |
| 13 | Cerebral inclusion bodies (HP:0100314) | 4.75666137 |
| 14 | Limb hypertonia (HP:0002509) | 4.64144323 |
| 15 | Abnormality of the parathyroid morphology (HP:0011766) | 4.33189583 |
| 16 | Hypoventilation (HP:0002791) | 4.01411471 |
| 17 | Neoplasm of the peripheral nervous system (HP:0100007) | 3.86599013 |
| 18 | Progressive cerebellar ataxia (HP:0002073) | 3.77018967 |
| 19 | Slow saccadic eye movements (HP:0000514) | 3.75601735 |
| 20 | Acute necrotizing encephalopathy (HP:0006965) | 3.62629551 |
| 21 | Hypercortisolism (HP:0001578) | 3.60855726 |
| 22 | Diminished movement (HP:0002374) | 3.56989169 |
| 23 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.51614945 |
| 24 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.48575343 |
| 25 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.36928776 |
| 26 | Abnormality of saccadic eye movements (HP:0000570) | 3.31884372 |
| 27 | Myokymia (HP:0002411) | 3.28996698 |
| 28 | Focal seizures (HP:0007359) | 3.27364822 |
| 29 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.27071969 |
| 30 | Mitochondrial inheritance (HP:0001427) | 3.21172165 |
| 31 | Progressive macrocephaly (HP:0004481) | 3.16598293 |
| 32 | Delusions (HP:0000746) | 3.02470007 |
| 33 | Febrile seizures (HP:0002373) | 2.99481315 |
| 34 | Anosmia (HP:0000458) | 2.91382255 |
| 35 | Acute encephalopathy (HP:0006846) | 2.88085451 |
| 36 | Postural tremor (HP:0002174) | 2.87996160 |
| 37 | Vacuolated lymphocytes (HP:0001922) | 2.85373115 |
| 38 | Focal motor seizures (HP:0011153) | 2.83830629 |
| 39 | Myoclonus (HP:0001336) | 2.83503985 |
| 40 | Diplopia (HP:0000651) | 2.79464758 |
| 41 | Abnormality of binocular vision (HP:0011514) | 2.79464758 |
| 42 | Progressive inability to walk (HP:0002505) | 2.78327785 |
| 43 | Emotional lability (HP:0000712) | 2.74403114 |
| 44 | * Bradykinesia (HP:0002067) | 2.72491297 |
| 45 | Anxiety (HP:0000739) | 2.69383452 |
| 46 | Increased CSF lactate (HP:0002490) | 2.61645335 |
| 47 | Truncal ataxia (HP:0002078) | 2.59981688 |
| 48 | Hepatocellular necrosis (HP:0001404) | 2.52861441 |
| 49 | Retinal dysplasia (HP:0007973) | 2.52164864 |
| 50 | Neurofibrillary tangles (HP:0002185) | 2.49291479 |
| 51 | * Muscular hypotonia of the trunk (HP:0008936) | 2.49011350 |
| 52 | Hyperparathyroidism (HP:0000843) | 2.48241339 |
| 53 | Vaginal atresia (HP:0000148) | 2.46677229 |
| 54 | Neuroblastoma (HP:0003006) | 2.46144868 |
| 55 | Primitive neuroectodermal tumor (HP:0030065) | 2.46144868 |
| 56 | Neuroblastic tumors (HP:0004376) | 2.46144868 |
| 57 | Peripheral primitive neuroectodermal neoplasm (HP:0030067) | 2.46144868 |
| 58 | Genital tract atresia (HP:0001827) | 2.43234132 |
| 59 | Disproportionate tall stature (HP:0001519) | 2.43090269 |
| 60 | * Rigidity (HP:0002063) | 2.42022979 |
| 61 | Generalized tonic-clonic seizures (HP:0002069) | 2.41345880 |
| 62 | Hypotension (HP:0002615) | 2.37045025 |
| 63 | Thyroid carcinoma (HP:0002890) | 2.29766108 |
| 64 | Bicornuate uterus (HP:0000813) | 2.26882714 |
| 65 | Progressive neurologic deterioration (HP:0002344) | 2.26647847 |
| 66 | Atonic seizures (HP:0010819) | 2.19945006 |
| 67 | Increased hepatocellular lipid droplets (HP:0006565) | 2.18607135 |
| 68 | Depression (HP:0000716) | 2.18022313 |
| 69 | Mask-like facies (HP:0000298) | 2.15567112 |
| 70 | Supranuclear gaze palsy (HP:0000605) | 2.13476391 |
| 71 | Optic disc pallor (HP:0000543) | 2.12080085 |
| 72 | Horizontal nystagmus (HP:0000666) | 2.11336738 |
| 73 | Poor suck (HP:0002033) | 2.11084194 |
| 74 | Episodic fever (HP:0001954) | 2.10076404 |
| 75 | Cerebral edema (HP:0002181) | 2.09053036 |
| 76 | Abnormal eating behavior (HP:0100738) | 2.08352358 |
| 77 | Ventricular fibrillation (HP:0001663) | 2.07162918 |
| 78 | Orthostatic hypotension (HP:0001278) | 2.05775103 |
| 79 | Status epilepticus (HP:0002133) | 2.05277252 |
| 80 | Fetal akinesia sequence (HP:0001989) | 2.01333467 |
| 81 | Gait ataxia (HP:0002066) | 2.01133809 |
| 82 | * Limb dystonia (HP:0002451) | 12.5230953 |
| 83 | Type II lissencephaly (HP:0007260) | 1.98230294 |
| 84 | Torticollis (HP:0000473) | 1.97598187 |
| 85 | Craniofacial dystonia (HP:0012179) | 1.96521182 |
| 86 | Abnormal gallbladder physiology (HP:0012438) | 1.96194346 |
| 87 | Cholecystitis (HP:0001082) | 1.96194346 |
| 88 | Rapidly progressive (HP:0003678) | 1.94936671 |
| 89 | Bowel diverticulosis (HP:0005222) | 1.91820169 |
| 90 | Resting tremor (HP:0002322) | 1.90186546 |
| 91 | Dysautonomia (HP:0002459) | 1.89012893 |
| 92 | Lipid accumulation in hepatocytes (HP:0006561) | 1.88746540 |
| 93 | Paraparesis (HP:0002385) | 1.88734841 |
| 94 | Agitation (HP:0000713) | 1.88346349 |
| 95 | Choreoathetosis (HP:0001266) | 1.88158712 |
| 96 | Neuronal loss in central nervous system (HP:0002529) | 1.85888155 |
| 97 | Epileptic encephalopathy (HP:0200134) | 1.84926467 |
| 98 | Focal dystonia (HP:0004373) | 1.83293803 |
| 99 | Papilledema (HP:0001085) | 1.82498956 |
| 100 | Leukodystrophy (HP:0002415) | 1.81929014 |
| 101 | Hepatic necrosis (HP:0002605) | 1.81102995 |
| 102 | Renal Fanconi syndrome (HP:0001994) | 1.79952363 |
| 103 | Goiter (HP:0000853) | 1.77365828 |
| 104 | Inability to walk (HP:0002540) | 1.75767815 |
| 105 | Gaze-evoked nystagmus (HP:0000640) | 1.73838819 |
| 106 | Increased intramyocellular lipid droplets (HP:0012240) | 1.73612618 |
| 107 | Coronal craniosynostosis (HP:0004440) | 1.73594944 |
| 108 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.72628791 |
| 109 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.72489334 |
| 110 | Akinesia (HP:0002304) | 1.71218178 |
| 111 | Neonatal onset (HP:0003623) | 1.70961553 |
| 112 | Esotropia (HP:0000565) | 1.70018400 |
| 113 | Adrenal overactivity (HP:0002717) | 1.69829771 |
| 114 | Respiratory failure (HP:0002878) | 1.69100506 |
| 115 | Renal dysplasia (HP:0000110) | 1.68157716 |
| 116 | Exercise intolerance (HP:0003546) | 1.68135046 |
| 117 | Dialeptic seizures (HP:0011146) | 1.64495913 |
| 118 | Polyphagia (HP:0002591) | 1.63874318 |
| 119 | Abnormal hair whorl (HP:0010721) | 1.63690785 |
| 120 | Absence seizures (HP:0002121) | 1.63533012 |
| 121 | Incomplete penetrance (HP:0003829) | 1.62644771 |
| 122 | Psychosis (HP:0000709) | 1.61648627 |
| 123 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.60908271 |
| 124 | Hemiplegia (HP:0002301) | 1.60867963 |
| 125 | Dysmetria (HP:0001310) | 1.60225483 |
| 126 | Mutism (HP:0002300) | 1.59539521 |
| 127 | Dysostosis multiplex (HP:0000943) | 1.57346738 |
| 128 | Oligodactyly (hands) (HP:0001180) | 1.56580920 |
| 129 | Exertional dyspnea (HP:0002875) | 1.52741681 |
| 130 | Gout (HP:0001997) | 1.50944994 |
| 131 | Bradycardia (HP:0001662) | 1.45528238 |
| 132 | Striae distensae (HP:0001065) | 1.44627405 |
| 133 | Respiratory difficulties (HP:0002880) | 1.42983896 |
| 134 | Variable expressivity (HP:0003828) | 1.42512550 |
| 135 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.39120046 |
| 136 | Fibular hypoplasia (HP:0003038) | 1.36366115 |
| 137 | Irritability (HP:0000737) | 1.36320256 |
| 138 | Dementia (HP:0000726) | 1.35901590 |
| 139 | Thickened helices (HP:0000391) | 1.34582921 |
| 140 | Hyperphosphaturia (HP:0003109) | 1.34252277 |
| 141 | Epileptiform EEG discharges (HP:0011182) | 1.34167928 |
| 142 | Gait imbalance (HP:0002141) | 1.31452779 |
| 143 | Drooling (HP:0002307) | 1.31138183 |
| 144 | Poor eye contact (HP:0000817) | 1.30707431 |
| 145 | EEG with generalized epileptiform discharges (HP:0011198) | 1.28696901 |
| 146 | Hypsarrhythmia (HP:0002521) | 1.28330062 |
| 147 | Generalized myoclonic seizures (HP:0002123) | 1.28115305 |
| 148 | Metabolic alkalosis (HP:0200114) | 1.25640764 |
| 149 | Excessive salivation (HP:0003781) | 1.21745000 |
| 150 | Impaired smooth pursuit (HP:0007772) | 1.18558112 |
| 151 | Chronic hepatic failure (HP:0100626) | 1.15602067 |
| 152 | Zonular cataract (HP:0010920) | 1.15318350 |
| 153 | Glossoptosis (HP:0000162) | 1.14576411 |
| 154 | Cerebral hypomyelination (HP:0006808) | 1.13662331 |
| 155 | Ankyloglossia (HP:0010296) | 1.12953474 |
| 156 | Spastic tetraplegia (HP:0002510) | 1.12639205 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 7.13935447 |
| 2 | MAPKAPK5 | 6.12010754 |
| 3 | MAP3K12 | 4.71617134 |
| 4 | CSNK1G3 | 4.02189725 |
| 5 | GRK5 | 3.64950245 |
| 6 | PINK1 | 3.50768867 |
| 7 | CSNK1G2 | 3.46536789 |
| 8 | PNCK | 3.24153310 |
| 9 | GRK6 | 3.22174371 |
| 10 | CSNK1G1 | 3.05691959 |
| 11 | MAP3K9 | 2.86004376 |
| 12 | PLK2 | 2.50053030 |
| 13 | MAP3K4 | 2.47731775 |
| 14 | ARAF | 2.41045937 |
| 15 | FGR | 2.30866211 |
| 16 | MAP2K7 | 2.27874044 |
| 17 | MAP2K4 | 2.23972796 |
| 18 | RET | 2.02725713 |
| 19 | PTK2B | 1.87607574 |
| 20 | BCKDK | 1.78604603 |
| 21 | WNK4 | 1.77000329 |
| 22 | MINK1 | 1.71217708 |
| 23 | ADRBK2 | 1.69989605 |
| 24 | STK39 | 1.69852516 |
| 25 | PKN2 | 1.69670549 |
| 26 | MAP3K13 | 1.48038475 |
| 27 | CAMK2B | 1.44557295 |
| 28 | NTRK1 | 1.40580566 |
| 29 | CDK15 | 1.34704419 |
| 30 | CDK18 | 1.32404768 |
| 31 | CAMK2D | 1.28664668 |
| 32 | EPHA4 | 1.28140710 |
| 33 | LATS2 | 1.27224292 |
| 34 | NME1 | 1.26745603 |
| 35 | CDK14 | 1.23821567 |
| 36 | CDK11A | 1.22327773 |
| 37 | KSR2 | 1.20588173 |
| 38 | PTK2 | 1.19252903 |
| 39 | MARK1 | 1.15464910 |
| 40 | CDK5 | 1.05100565 |
| 41 | TSSK6 | 1.02523035 |
| 42 | NTRK3 | 1.00872523 |
| 43 | CAMK2G | 0.98386563 |
| 44 | * CAMK2A | 0.94383679 |
| 45 | ADRBK1 | 0.90190617 |
| 46 | FLT3 | 0.88933027 |
| 47 | CASK | 0.81977396 |
| 48 | MYLK | 0.79436297 |
| 49 | DYRK1A | 0.78462820 |
| 50 | ERBB4 | 0.78454383 |
| 51 | RPS6KA5 | 0.78096392 |
| 52 | NTRK2 | 0.77058786 |
| 53 | PLK3 | 0.75363220 |
| 54 | EIF2AK2 | 0.68297085 |
| 55 | EEF2K | 0.67889923 |
| 56 | BMPR1B | 0.66747702 |
| 57 | SCYL2 | 0.65859227 |
| 58 | UHMK1 | 0.65588183 |
| 59 | FES | 0.64616721 |
| 60 | MOS | 0.62942157 |
| 61 | SIK2 | 0.62405725 |
| 62 | MAPK13 | 0.61426440 |
| 63 | PRKCG | 0.59914967 |
| 64 | STK16 | 0.59669533 |
| 65 | KSR1 | 0.59174054 |
| 66 | PHKG1 | 0.52339226 |
| 67 | PHKG2 | 0.52339226 |
| 68 | RIPK4 | 0.52284392 |
| 69 | WNK1 | 0.51826808 |
| 70 | MAP3K5 | 0.51214776 |
| 71 | SYK | 0.51152218 |
| 72 | CDK19 | 0.50684298 |
| 73 | MAP3K11 | 0.50616974 |
| 74 | OXSR1 | 0.50318623 |
| 75 | CAMKK2 | 0.50032180 |
| 76 | CAMK1G | 0.46901455 |
| 77 | MARK2 | 0.45939829 |
| 78 | PAK3 | 0.43515939 |
| 79 | TYRO3 | 0.42718128 |
| 80 | CSNK1A1 | 0.42161072 |
| 81 | CSNK1D | 0.41888032 |
| 82 | MAP3K1 | 0.40206669 |
| 83 | CHEK2 | 0.40007544 |
| 84 | BRAF | 0.38685844 |
| 85 | TYK2 | 0.37777007 |
| 86 | PAK6 | 0.36951048 |
| 87 | ROCK2 | 0.36356637 |
| 88 | CSNK1E | 0.35439047 |
| 89 | SGK1 | 0.33320676 |
| 90 | FYN | 0.32658569 |
| 91 | CDK9 | 0.31619474 |
| 92 | LMTK2 | 0.30451171 |
| 93 | RAF1 | 0.29879477 |
| 94 | PRKAA1 | 0.28511579 |
| 95 | MAPKAPK3 | 0.28066984 |
| 96 | CAMKK1 | 0.26454925 |
| 97 | PRKACA | 0.23894250 |
| 98 | SGK494 | 0.23739669 |
| 99 | SGK223 | 0.23739669 |
| 100 | MAPKAPK2 | 0.23342797 |
| 101 | PRKACG | 0.23304692 |
| 102 | DAPK1 | 0.22655563 |
| 103 | TRPM7 | 0.22396744 |
| 104 | STK11 | 0.21991095 |
| 105 | MAP2K1 | 0.21773987 |
| 106 | ABL2 | 0.21560399 |
| 107 | PRKACB | 0.21555583 |
| 108 | SIK1 | 0.21527548 |
| 109 | ACVR1B | 0.21354970 |
| 110 | PRKCZ | 0.21088685 |
| 111 | WNK3 | 0.20530772 |
| 112 | MAPK12 | 0.20464224 |
| 113 | CSNK2A2 | 0.20021337 |
| 114 | IGF1R | 0.19350304 |
| 115 | ERN1 | 0.19197117 |
| 116 | PKN1 | 0.18382548 |
| 117 | PRKCH | 0.18252623 |
| 118 | BMPR2 | 0.16838855 |
| 119 | PDK1 | 0.16262595 |
| 120 | DYRK2 | 0.16236021 |
| 121 | LYN | 0.15962047 |
| 122 | CSNK1A1L | 0.15823510 |
| 123 | RPS6KA3 | 0.14800384 |
| 124 | DAPK2 | 0.14564817 |
| 125 | PRKCB | 0.14343592 |
| 126 | BMX | 0.14316657 |
| 127 | FER | 0.14143345 |
| 128 | PRKCA | 0.13976284 |
| 129 | SGK2 | 0.12081443 |
| 130 | PRKG2 | 0.11834978 |
| 131 | PRKG1 | 0.11753143 |
| 132 | STK38 | 0.11644571 |
| 133 | CDK3 | 0.11291398 |
| 134 | SRC | 0.11254593 |
| 135 | BCR | 0.11129999 |
| 136 | PRKCE | 0.10039408 |
| 137 | BRSK2 | 0.09215381 |
| 138 | ROCK1 | 0.06210930 |
| 139 | MAPK10 | 0.01769221 |
| 140 | PRKD1 | 0.00926850 |
| 141 | INSRR | -0.0067065 |
| 142 | TLK1 | -0.0050762 |
| 143 | MAPK8 | -0.0004662 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 4.65924569 |
| 2 | * Cocaine addiction_Homo sapiens_hsa05030 | 4.38307454 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 3.95861757 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.80940995 |
| 5 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 3.66594388 |
| 6 | * Amphetamine addiction_Homo sapiens_hsa05031 | 3.14388884 |
| 7 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.11990861 |
| 8 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.92019647 |
| 9 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.91306222 |
| 10 | Nicotine addiction_Homo sapiens_hsa05033 | 2.73474832 |
| 11 | * Dopaminergic synapse_Homo sapiens_hsa04728 | 2.65432445 |
| 12 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.55831107 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.51336475 |
| 14 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.44515009 |
| 15 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.29824152 |
| 16 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.11947577 |
| 17 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.88941647 |
| 18 | Huntingtons disease_Homo sapiens_hsa05016 | 1.87504971 |
| 19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.82252361 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.81177058 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.79810942 |
| 22 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.65527842 |
| 23 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.59326118 |
| 24 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.58763028 |
| 25 | GABAergic synapse_Homo sapiens_hsa04727 | 1.52505465 |
| 26 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.50270341 |
| 27 | Long-term potentiation_Homo sapiens_hsa04720 | 1.50004451 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.45814971 |
| 29 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.40833391 |
| 30 | Insulin secretion_Homo sapiens_hsa04911 | 1.37586012 |
| 31 | Long-term depression_Homo sapiens_hsa04730 | 1.36432777 |
| 32 | Circadian entrainment_Homo sapiens_hsa04713 | 1.34163999 |
| 33 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.28827671 |
| 34 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.27736275 |
| 35 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.27114244 |
| 36 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.22573059 |
| 37 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.22427144 |
| 38 | Gap junction_Homo sapiens_hsa04540 | 1.21154371 |
| 39 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.17731091 |
| 40 | * Alcoholism_Homo sapiens_hsa05034 | 1.15406423 |
| 41 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.14806493 |
| 42 | Salivary secretion_Homo sapiens_hsa04970 | 1.10242849 |
| 43 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.10018923 |
| 44 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.08531958 |
| 45 | Morphine addiction_Homo sapiens_hsa05032 | 1.07615445 |
| 46 | Renin secretion_Homo sapiens_hsa04924 | 1.07549148 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.07163910 |
| 48 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.02097217 |
| 49 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.00966125 |
| 50 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.96125921 |
| 51 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.95941983 |
| 52 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93177205 |
| 53 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.92906631 |
| 54 | Olfactory transduction_Homo sapiens_hsa04740 | 0.91030651 |
| 55 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.88872503 |
| 56 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.86424213 |
| 57 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.84999515 |
| 58 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.81537391 |
| 59 | Taste transduction_Homo sapiens_hsa04742 | 0.79274311 |
| 60 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.77987081 |
| 61 | Thyroid cancer_Homo sapiens_hsa05216 | 0.77370073 |
| 62 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.72774345 |
| 63 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.71920784 |
| 64 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.68496521 |
| 65 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.68036353 |
| 66 | Phagosome_Homo sapiens_hsa04145 | 0.63141694 |
| 67 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.61777870 |
| 68 | Retinol metabolism_Homo sapiens_hsa00830 | 0.60576693 |
| 69 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.58714313 |
| 70 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.57139669 |
| 71 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.56530406 |
| 72 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.54496168 |
| 73 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.50885901 |
| 74 | Melanogenesis_Homo sapiens_hsa04916 | 0.50859972 |
| 75 | ABC transporters_Homo sapiens_hsa02010 | 0.50059992 |
| 76 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.47845718 |
| 77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47632790 |
| 78 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.43261448 |
| 79 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.42666851 |
| 80 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.42124038 |
| 81 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.39376042 |
| 82 | Base excision repair_Homo sapiens_hsa03410 | 0.38399702 |
| 83 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.38149387 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33676731 |
| 85 | Prion diseases_Homo sapiens_hsa05020 | 0.32870093 |
| 86 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.31639306 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.31472576 |
| 88 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.30721715 |
| 89 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.30178351 |
| 90 | Other glycan degradation_Homo sapiens_hsa00511 | 0.29586518 |
| 91 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.29046884 |
| 92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27632733 |
| 93 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.26274931 |
| 94 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.25914532 |
| 95 | Proteasome_Homo sapiens_hsa03050 | 0.25571520 |
| 96 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25253187 |
| 97 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.24659051 |
| 98 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.23920607 |
| 99 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.23915706 |
| 100 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.22843876 |
| 101 | Melanoma_Homo sapiens_hsa05218 | 0.21520657 |
| 102 | Axon guidance_Homo sapiens_hsa04360 | 0.21499312 |
| 103 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.20542697 |
| 104 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.20425538 |
| 105 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.20381772 |
| 106 | Carbon metabolism_Homo sapiens_hsa01200 | 0.19265632 |
| 107 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.18924262 |
| 108 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.18359392 |
| 109 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.18264390 |
| 110 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.18166598 |
| 111 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.16885305 |
| 112 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.16079273 |
| 113 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.15905944 |
| 114 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.14477707 |
| 115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.13827623 |
| 116 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.13747490 |
| 117 | Sulfur relay system_Homo sapiens_hsa04122 | 0.13709094 |
| 118 | Glioma_Homo sapiens_hsa05214 | 0.13404930 |
| 119 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.12481145 |
| 120 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.12231448 |
| 121 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.12052884 |
| 122 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.11517185 |
| 123 | Endocytosis_Homo sapiens_hsa04144 | 0.11011700 |
| 124 | Phototransduction_Homo sapiens_hsa04744 | 0.09399288 |
| 125 | Circadian rhythm_Homo sapiens_hsa04710 | 0.08757279 |
| 126 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.08284375 |
| 127 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.07981581 |
| 128 | Lysosome_Homo sapiens_hsa04142 | 0.06813079 |
| 129 | Bile secretion_Homo sapiens_hsa04976 | 0.06711729 |

